China Medicine Announces Conference Call to Discuss Second Quarter 2009 Results

Friday, September 18, 2009 General News J E 4
GUANGZHOU, China, Aug. 10 China Medicine Corporation(OTC Bulletin Board: CHME) ("China Medicine" or "the Company"), a leadingdeveloper and distributor of prescription and over the counter pharmaceuticals,traditional Chinese medicines (TCM), nutritional and dietary supplements, andmedical devices and medical formulations, today announced that it will conducta conference call at 10:00 a.m. Eastern Time on Thursday, August 13, 2009, todiscuss its second quarter 2009 results.

Joining Mr. Senshan Yang, Chairman and Chief Executive Officer of ChinaMedicine Corporation, will be Ms. Huizhen Yu, Chief Financial Officer. TheCompany plans to make an earnings announcement prior to the call.

To participate in the live conference call, please dial the followingnumber five to ten minutes prior to the scheduled conference call time:866.800.8648. International callers should dial 617.614.2702, conferencepasscode: 175 848 10.

If you are unable to participate in the call at this time, a replay willbe available for 14 days starting on Thursday, August 13, at 12:00 p.m.Eastern Time. To access the replay, dial 888.286.8010, international callersdial 617.801.6888, and enter the passcode 442 846 06.

About China Medicine Corporation

China Medicine Corporation is a leading pharmaceutical company thatdiscovers and develops medical formulations and distributes over 2,400pharmaceutical products in China including prescription and over the counter("OTC") drugs, traditional Chinese medicine products, herbs and dietary-supplements. The Company distributes its products to wholesale distributors in28 provinces, more than 300 hospitals, 500 medicine companies, and 1,788 drugstores throughout China. The Company actively develops a number of proprietaryproducts for a variety of uses, including oncology, high blood pressure andthe removal of toxins from food and animal feeds. For more information visitthe Company's website at .For more information, please contact: Company Contact: Ms. Huizhen Yu Chief Financial Officer China Medicine Corporation Tel: +86-20-8739-1718 Email: Investor Relations Contact: Mr. Crocker Coulson President CCG Investor Relations Tel: +1-646-213-1915 (NY Office) Email: Web:

SOURCE China Medicine Corporation


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
The National Center for Genome Resources Studies C...
Nielsen Announces Entry Deadline Extension for the...